Literature DB >> 33670864

Performance of Existing Definitions and Tests for the Diagnosis of Invasive Fungal Diseases other than Invasive Candidiasis and Invasive Aspergillosis in Critically Ill, Adult Patients: A Systematic Review with Qualitative Evidence Synthesis.

Daniele R Giacobbe1,2, Andrea Cortegiani3,4, Ilias Karaiskos5, Toine Mercier6,7, Sofia Tejada8,9, Maddalena Peghin10, Cecilia Grecchi11,12, Chiara Rebuffi13, Erika Asperges11, Valentina Zuccaro11, Luigia Scudeller14, Matteo Bassetti1,2.   

Abstract

The Fungal Infections Definitions in Intensive Care Unit (ICU) patients (FUNDICU) project aims to provide standard sets of definitions for invasive fungal diseases (IFDs) in critically ill, adult patients, including invasive aspergillosis (IA), invasive candidiasis (IC), Pneumocystis jirovecii pneumonia (PJP), and other non-IA, non-IC IFDs. The first step of the project was the conduction of separated systematic reviews of the characteristics and applicability to critically ill, adult patients outside classical populations at risk (hematology patients, solid organ transplant recipients) of available definitions and diagnostic tests for IFDs. We report here the results of two systematic reviews exploring the performance of available definitions and tests, for PJP and for other non-IA, non-IC IFDs. Starting from 2585 and 4584 records for PJP and other IFDs, respectively, 89 and 61 studies were deemed as eligible for full-text evaluation. However, only two studies for PJP and no studies for other IFDs met the FUNDICU protocol criteria for inclusion in qualitative synthesis. Currently, there is no sufficient solid data for directly evaluating the performance of existing definitions and laboratory tests for the diagnosis of PJP and other non-IA, non-IC IFDs in critically ill adult patients outside classical populations at risk.

Entities:  

Keywords:  IFD; PJP; biomarker; diagnosis; invasive fungal diseases; pneumocystis

Year:  2021        PMID: 33670864      PMCID: PMC7997529          DOI: 10.3390/jof7030176

Source DB:  PubMed          Journal:  J Fungi (Basel)        ISSN: 2309-608X


  25 in total

1.  Quantitative PCR to diagnose Pneumocystis pneumonia in immunocompromised non-HIV patients.

Authors:  K Mühlethaler; K Bögli-Stuber; S Wasmer; C von Garnier; P Dumont; A Rauch; K Mühlemann; C Garzoni
Journal:  Eur Respir J       Date:  2011-09-15       Impact factor: 16.671

2.  Diagnosis of Pneumocystis pneumonia by real-time PCR in patients with various underlying diseases.

Authors:  Shu-Li Yang; Ying-Hao Wen; Yu-Shan Wu; Mei-Chia Wang; Pi-Yueh Chang; Shuan Yang; Jang-Jih Lu
Journal:  J Microbiol Immunol Infect       Date:  2019-10-07       Impact factor: 4.399

Review 3.  Invasive mould infections in the ICU setting: complexities and solutions.

Authors:  Matteo Bassetti; Emilio Bouza
Journal:  J Antimicrob Chemother       Date:  2017-03-01       Impact factor: 5.790

4.  A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients.

Authors:  Stijn I Blot; Fabio Silvio Taccone; Anne-Marie Van den Abeele; Pierre Bulpa; Wouter Meersseman; Nele Brusselaers; George Dimopoulos; José A Paiva; Benoit Misset; Jordi Rello; Koenraad Vandewoude; Dirk Vogelaers
Journal:  Am J Respir Crit Care Med       Date:  2012-04-19       Impact factor: 21.405

5.  Acute respiratory failure due to pneumocystis pneumonia in patients without human immunodeficiency virus infection: outcome and associated features.

Authors:  Emir Festic; Ognjen Gajic; Andrew H Limper; Timothy R Aksamit
Journal:  Chest       Date:  2005-08       Impact factor: 9.410

Review 6.  Epidemiology of candidemia in intensive care units.

Authors:  Emilio Bouza; Patricia Muñoz
Journal:  Int J Antimicrob Agents       Date:  2008-11       Impact factor: 5.283

Review 7.  Performance of existing definitions and tests for the diagnosis of invasive aspergillosis in critically ill, adult patients: A systematic review with qualitative evidence synthesis.

Authors:  M Bassetti; D R Giacobbe; C Grecchi; C Rebuffi; V Zuccaro; L Scudeller
Journal:  J Infect       Date:  2020-04-21       Impact factor: 6.072

Review 8.  Mucormycosis in Burn Patients.

Authors:  Pauline Devauchelle; Mathieu Jeanne; Emilie Fréalle
Journal:  J Fungi (Basel)       Date:  2019-03-21

9.  Risk factors and clinical characteristics of Pneumocystis jirovecii pneumonia in lung cancer.

Authors:  Eun Hye Lee; Eun Young Kim; Sang Hoon Lee; Yun Ho Roh; Ah Young Leem; Joo Han Song; Song Yee Kim; Kyung Soo Chung; Ji Ye Jung; Young Ae Kang; Young Sam Kim; Joon Chang; Moo Suk Park
Journal:  Sci Rep       Date:  2019-02-14       Impact factor: 4.379

10.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  PLoS Med       Date:  2009-07-21       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.